Ligase Targeting Drug Development Summit
Evvnt Promotion / evvnt
07.05.2024 - 09.05.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temi della conferenza
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2174653-3?pid=4832
Speakers: Andreas Kraemer Principal Investigator Goethe University Frankfurt am Main and Structural Genomics Consortium, and more
URL:
Brochure: https://go.evvnt.com/2174653-3?pid=4832
Speakers: Andreas Kraemer Principal Investigator Goethe University Frankfurt am Main and Structural Genomics Consortium, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2174653-2?pid=4832
Ms. Isabella Hunter
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
